On 28 April 2023, Mölnlycke entered into a new EUR 350 million multicurrency revolving credit facility agreement. The facility has a tenor of five years with two one-year extension options and is provided by a syndicate of seven Nordic and international banks.
The facility is a refinancing of the existing and undrawn revolving credit facility from 2017 and will be used as a backup for general corporate purposes.
Mölnlycke is a world-leading medical products and solutions company that equips healthcare professionals to achieve the best patient, clinical and economic outcomes. Mölnlycke has around 8,700 employees and operates in more than 100 countries worldwide, with its headquarters in Gothenburg, Sweden.
Mölnlycke was advised by Mannheimer Swartling in the transaction.